Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling. - Institut Pasteur Access content directly
Journal Articles Cancer Research Year : 2018

Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.

Abstract

A growing number of observations has suggested that plasmacytoid dendritic cells (pDC) play a critical role in tumor biology. In patients, infiltration of tumors by pDCs generally correlates with a poor prognosis, suggesting that pDCs may play an important role in the host-tumor relationship. Here, we analyze the influence of pDCs in solid tumor development using two different tumor models: TC-1 and B16-OVA. Phenotypic and functional gene profiling analysis of tumor-associated pDCs showed that the tumor microenvironment affected their activation status and ability to produce cytokines and chemokines. In addition, tumor cells secreted factors that inhibit the ability of pDCs to produce type I IFN. Among the various cytokines and chemokines produced by the tumor cells, we demonstrate that TGFβ is the main factor responsible for this inhibition. Using a mouse model deficient for pDCs, we also show that pDCs promote TC-1 tumor growth and that natural killer (NK) cells and regulatory T cells are involved in the protumoral effect of pDCs. Overall, our results evidence the cross-talk among pDCs, NK, and regulatory T cells in the promotion of tumor growth and their role in the development of antitumor immune responses.Significance: These findings highlight the importance of pDCs in the cross-talk between tumor cells and the immune system
Fichier principal
Vignette du fichier
0008-5472.CAN-17-2719.pdf (3.35 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-01942405 , version 1 (04-12-2018)

Licence

Attribution - NonCommercial - ShareAlike

Identifiers

Cite

Mariana Terra, Marine Oberkampf, Catherine Fayolle, Pierre Rosenbaum, Camille Guillerey, et al.. Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.. Cancer Research, 2018, 78 (11), pp.3014-3026. ⟨10.1158/0008-5472.CAN-17-2719⟩. ⟨pasteur-01942405⟩
165 View
247 Download

Altmetric

Share

Gmail Facebook X LinkedIn More